Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 04, 2021

SELL
$4.04 - $5.31 $54,305 - $71,377
-13,442 Closed
0 $0
Q3 2020

Oct 26, 2020

SELL
$3.64 - $7.76 $106,652 - $227,368
-29,300 Reduced 68.55%
13,442 $57,000
Q2 2020

Jul 31, 2020

BUY
$4.78 - $8.26 $97,488 - $168,462
20,395 Added 91.27%
42,742 $296,000
Q1 2020

Apr 23, 2020

BUY
$4.0 - $21.53 $89,388 - $481,130
22,347 New
22,347 $89,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $185M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Altium Wealth Management LLC Portfolio

Follow Altium Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altium Wealth Management LLC with notifications on news.